Inventor · disambiguated record
Wenqing Yao
Also filed as: YAO WENQING
224 granted patents·94 pending applications·3,177 citations·filing 1996–2025
99Inventor score
Top patents by PatentIndex Score
318 records- 0199US11566026B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Jan 31, 2023·16 cites·19 claims
- 0299US8691807B2Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitorsYAO WENQING·Filed 2012·Granted Apr 8, 2014·114 cites·44 claims
- 0399US7767675B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2007·Granted Aug 3, 2010·85 cites·85 claims
- 0498US11866435B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2022·Granted Jan 9, 2024·7 cites·21 claims
- 0598US11787793B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2022·Granted Oct 17, 2023·9 cites·25 claims
- 0698US11718605B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Aug 8, 2023·11 cites·28 claims
- 0798US11673883B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Jun 13, 2023·12 cites·29 claims
- 0898US11613536B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2021·Granted Mar 28, 2023·15 cites·15 claims
- 0998US11608337B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Mar 21, 2023·15 cites·22 claims
- 1098US11572366B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Feb 7, 2023·15 cites·28 claims
- 1198US11530214B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2021·Granted Dec 20, 2022·7 cites·26 claims
- 1298US11465981B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Oct 11, 2022·18 cites·28 claims
- 1398US11414433B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Aug 16, 2022·23 cites·50 claims
- 1498US11407749B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Aug 9, 2022·23 cites·24 claims
- 1598US11401279B2Pyrido[3,2-d]pyrimidine compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Aug 2, 2022·24 cites·14 claims
- 1698US11339149B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted May 24, 2022·24 cites·20 claims
- 1798US11173162B2Bicyclic heterocycles as FGFR4 inhibitorsINCYTE CORP·Filed 2020·Granted Nov 16, 2021·22 cites·19 claims
- 1898US11124511B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Sep 21, 2021·28 cites·35 claims
- 1998US11053246B2Substituted tricyclic compounds as FGFR inhibitorsINCYTE CORP·Filed 2020·Granted Jul 6, 2021·23 cites·10 claims
- 2098US11014923B2Bicyclic heterocycles as FGFR4 inhibitorsINCYTE CORP·Filed 2020·Granted May 25, 2021·22 cites·32 claims
- 2198US10947230B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2019·Granted Mar 16, 2021·26 cites·44 claims
- 2298US10906920B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Feb 2, 2021·29 cites·41 claims
- 2398US10813930B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3INCYTE CORP·Filed 2019·Granted Oct 27, 2020·27 cites·42 claims
- 2498US10800768B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2019·Granted Oct 13, 2020·30 cites·18 claims
- 2598US10793565B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2019·Granted Oct 6, 2020·27 cites·16 claims
- 2698US10738048B2Bicyclic heterocycles as FGFR4 inhibitorsINCYTE CORP·Filed 2019·Granted Aug 11, 2020·28 cites·21 claims
- 2798US10669271B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2019·Granted Jun 2, 2020·40 cites·20 claims
- 2898US10632126B2Bicyclic heterocycles as FGFR4 inhibitorsINCYTE CORP·Filed 2019·Granted Apr 28, 2020·27 cites·8 claims
- 2998US10450313B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2018·Granted Oct 22, 2019·32 cites·16 claims
- 3098US10308644B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2017·Granted Jun 4, 2019·115 cites·16 claims
- 3198US10213427B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3INCYTE CORP·Filed 2016·Granted Feb 26, 2019·34 cites·39 claims
- 3298US10131667B2Substituted tricyclic compounds as FGFR inhibitorsINCYTE CORP·Filed 2017·Granted Nov 20, 2018·35 cites·16 claims
- 3398US10040790B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2016·Granted Aug 7, 2018·36 cites·54 claims
- 3498US9801889B2Bicyclic heterocycles as FGFR4 inhibitorsINCYTE CORP·Filed 2017·Granted Oct 31, 2017·40 cites·35 claims
- 3598US9758523B2Triazolopyridines and triazolopyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2015·Granted Sep 12, 2017·21 cites·14 claims
- 3698US9745311B2Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitorsINCYTE CORP·Filed 2016·Granted Aug 29, 2017·45 cites·22 claims
- 3798US9695167B2Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2015·Granted Jul 4, 2017·33 cites·41 claims
- 3898US9611267B2Substituted tricyclic compounds as FGFR inhibitorsINCYTE CORP·Filed 2013·Granted Apr 4, 2017·54 cites·4 claims
- 3998US9611269B2Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitorsINCYTE CORP·Filed 2015·Granted Apr 4, 2017·45 cites·24 claims
- 4098US9580423B2Bicyclic heterocycles as FGFR4 inhibitorsINCYTE CORP·Filed 2016·Granted Feb 28, 2017·42 cites·31 claims
- 4198US9533984B2Bicyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2014·Granted Jan 3, 2017·42 cites·6 claims
- 4298US9023840B2Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitorsINCYTE CORP·Filed 2014·Granted May 5, 2015·64 cites·21 claims
- 4398US8309718B24-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitorsLI YUN-LONG·Filed 2008·Granted Nov 13, 2012·109 cites·35 claims
- 4497US11840534B2Substituted tricyclic compounds as FGFR inhibitorsINCYTE CORP·Filed 2021·Granted Dec 12, 2023·4 cites·15 claims
- 4597US11667635B2Bicyclic heterocycles as FGFR4 inhibitorsINCYTE CORP·Filed 2021·Granted Jun 6, 2023·7 cites·22 claims
- 4697US11542265B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Jan 3, 2023·8 cites·43 claims
- 4797US11535615B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Dec 27, 2022·9 cites·21 claims
- 4897US11492354B2Indazole compounds and uses thereofINCYTE CORP·Filed 2020·Granted Nov 8, 2022·8 cites·71 claims
- 4997US11242343B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2020·Granted Feb 8, 2022·12 cites·27 claims
- 5097US10934288B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Mar 2, 2021·13 cites·8 claims
Showing the top 50 of 318 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wenqing Yao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →